Byetta is contraindicated in severe renal impairment (eGFR below 30 mL/min/1.73m) and should be used with caution in moderate renal impairment
DPP-4 inhibitors have an attractive side effect profile that encourages the prevention of weight gain without hypoglycemia, making this class of agents an option for early intervention in the management of type 2 diabetes
Namun, penggunaan jangka panjang sebaiknya dikonsultasikan dengan dokter untuk memantau fungsi ginjal
- Benefits compound over time with consistent use
In the UC mouse model, LLC exhibited multifaceted regulatory effects, including mitigating inflammatory responses, suppressing pyroptosis, modulating local immune status, enhancing intestinal barrier function, and reshaping gut microbiota composition, with an overall efficacy superior to that of raw LL